Nifty

:

25149.85

Sensex

:

82500.47

-205.40 (-0.81%)
-689.81 (-0.83%)

Login

Nifty
Sensex

:
:

25149.85
82500.47

-205.40 (-0.81%)
-689.81 (-0.83%)

Abbott India Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

N/A

BSE: 500488 | NSE: ABBOTINDIA

Watchlist

NSE BSE

34420.00

11-Jul-2025

Open
High
Low
Previous Close

34545
34735
34310
34555.00

Volume
Traded Value (lacs)
52 Week High
52 Week Low

3025
104428395
37000
25325

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

73,118.74
51.69
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

71,490.82
1.38%
17.27

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

9.83
7.40
5.98

EBITDA CAGR (%)

10 Years
5 Years
3 Years

16.66
13.95
6.08

PAT CAGR (%)

10 Years
5 Years
3 Years

18.03
15.17
14.57

P:E (Median)

8 Years
5 Years
3 Years

48.39
49.41
48.70

P:BV (Average)

8 Years
5 Years
3 Years

15.10
15.14
15.70

EV:EBITDA (Average)

8 Years
5 Years
3 Years

30.13
33.26
32.88

Earnings Forecasts:

(Updated: 06-06-2025)

Description 2024 2025 2026 2027
Adj EPS 565.28 665.62 742.57 841.2
P/E Ratio 11.26 9.56 8.57 7.57
Revenue 5849 6409 6863 7528
EBITDA 1453 1695 1904 2159
Net Income 1201 1414 1578 1788
ROA 24.6 25.5 25.3 26.7
P/B Ratio 3.66 3.20 2.86 2.45
ROE 34.88 35.66 35.61 35.44
FCFF 1308 1085 1423 1652
FCFF Yield 2.09 1.73 2.27 2.64
Net Debt -2051 -1431 329 215
BVPS 1740.71 1992.07 2226.5 2593.8

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 1,604.59 1,438.63 11.54% 1,614.28 1,437.14 12.33% 1,632.67 1,494.14 9.27% 1,557.61 1,479.00 5.32%
Expenses 1,176.05 1,109.10 6.04% 1,178.19 1,049.45 12.27% 1,193.71 1,113.26 7.23% 1,166.60 1,124.00 3.79%
EBITDA 428.54 329.53 30.05% 436.09 387.69 12.48% 438.96 380.88 15.25% 391.01 355.00 10.14%
EBIDTM 26.71% 22.91% 27.01% 26.98% 26.89% 25.49% 25.10% 24.00%
Other Income 76.02 81.15 -6.32% 71.75 55.61 29.02% 60.48 55.51 8.95% 67.33 56.00 20.23%
Interest 3.92 2.81 39.50% 2.26 3.17 -28.71% 2.50 3.13 -20.13% 2.75 3.34 -17.66%
Depreciation 17.93 18.19 -1.43% 17.99 17.97 0.11% 17.51 17.84 -1.85% 18.37 17.17 6.99%
PBT 482.71 389.68 23.87% 487.59 422.16 15.50% 479.43 415.42 15.41% 437.22 390.49 11.97%
Tax 115.67 102.62 12.72% 126.81 111.18 14.06% 120.82 102.48 17.90% 109.21 100.25 8.94%
PAT 367.04 287.06 27.86% 360.78 310.98 16.01% 358.61 312.94 14.59% 328.01 290.24 13.01%
PATM 22.87% 19.95% 22.35% 21.64% 21.96% 20.94% 21.06% 19.62%
EPS 173.13 135.41 27.86% 170.18 146.69 16.01% 169.16 147.61 14.60% 154.72 136.91 13.01%

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 6,409.15 5,848.91 5,348.73 4,913.32 4,310.02 4,093.14 3,678.60 3,298.50 2,902.56 2,614.50 2,289.33 Net Sales Growth 9.58% 9.35% 8.86% 14.00% 5.30% 11.27% 11.52% 13.64% 11.02% 14.20% Cost Of Goods Sold 3,496.78 3,220.61 2,975.06 2,657.21 2,390.92 2,315.63 2,088.60 1,900.43 1,714.96 1,494.45 1,314.45 Gross Profit 2,912.37 2,628.30 2,373.67 2,256.11 1,919.10 1,777.51 1,590.01 1,398.07 1,187.60 1,120.05 974.87 GP Margin 45.44% 44.94% 44.38% 45.92% 44.53% 43.43% 43.22% 42.39% 40.92% 42.84% 42.58% Total Expenditure 4,714.55 4,395.86 4,143.24 3,831.74 3,391.13 3,336.96 3,074.56 2,775.10 2,507.75 2,250.77 1,978.01 Power & Fuel Cost - 16.63 17.15 14.98 12.74 13.73 12.61 10.26 7.74 6.98 5.96 % Of Sales - 0.28% 0.32% 0.30% 0.30% 0.34% 0.34% 0.31% 0.27% 0.27% 0.26% Employee Cost - 576.58 563.59 579.46 492.65 476.11 435.58 393.69 345.27 341.09 305.40 % Of Sales - 9.86% 10.54% 11.79% 11.43% 11.63% 11.84% 11.94% 11.90% 13.05% 13.34% Manufacturing Exp. - 86.07 40.71 20.63 16.51 18.33 14.42 11.52 13.14 11.94 11.59 % Of Sales - 1.47% 0.76% 0.42% 0.38% 0.45% 0.39% 0.35% 0.45% 0.46% 0.51% General & Admin Exp. - 233.47 258.70 229.35 200.23 209.71 267.14 239.06 205.33 191.08 152.91 % Of Sales - 3.99% 4.84% 4.67% 4.65% 5.12% 7.26% 7.25% 7.07% 7.31% 6.68% Selling & Distn. Exp. - 210.47 217.97 249.77 199.90 222.07 191.15 156.94 148.33 152.27 135.60 % Of Sales - 3.60% 4.08% 5.08% 4.64% 5.43% 5.20% 4.76% 5.11% 5.82% 5.92% Miscellaneous Exp. - 52.03 70.06 80.34 78.18 81.38 65.05 63.19 72.98 52.96 135.60 % Of Sales - 0.89% 1.31% 1.64% 1.81% 1.99% 1.77% 1.92% 2.51% 2.03% 2.28% EBITDA 1,694.60 1,453.05 1,205.49 1,081.58 918.89 756.18 604.04 523.40 394.81 363.73 311.32 EBITDA Margin 26.44% 24.84% 22.54% 22.01% 21.32% 18.47% 16.42% 15.87% 13.60% 13.91% 13.60% Other Income 275.58 248.32 154.29 83.35 83.47 114.66 113.98 118.09 60.15 51.24 48.48 Interest 11.43 12.45 15.99 19.10 18.28 8.53 2.25 3.82 2.04 2.52 0.50 Depreciation 71.80 71.17 69.97 66.10 58.13 59.61 16.92 16.19 16.43 14.44 14.94 PBT 1,886.95 1,617.75 1,273.82 1,079.73 925.95 802.70 698.85 621.48 436.49 398.01 344.36 Tax 472.51 416.53 324.41 281.03 235.26 209.77 248.52 220.26 159.84 142.76 115.40 Tax Rate 25.04% 25.75% 25.47% 26.03% 25.41% 26.13% 35.56% 35.44% 36.62% 35.87% 33.51% PAT 1,414.44 1,201.22 949.41 798.70 690.69 592.93 450.33 401.22 276.65 255.25 228.96 PAT before Minority Interest 1,414.44 1,201.22 949.41 798.70 690.69 592.93 450.33 401.22 276.65 255.25 228.96 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 22.07% 20.54% 17.75% 16.26% 16.03% 14.49% 12.24% 12.16% 9.53% 9.76% 10.00% PAT Growth 17.75% 26.52% 18.87% 15.64% 16.49% 31.67% 12.24% 45.03% 8.38% 11.48% EPS 667.19 566.61 447.83 376.75 325.80 279.68 212.42 189.25 130.50 120.40 108.00

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 3,698.89 3,188.54 2,819.79 2,602.16 2,431.70 2,008.59 1,692.76 1,386.94 1,195.60 937.53 Share Capital 21.25 21.25 21.25 21.25 21.25 21.25 21.25 21.25 21.25 21.25 Total Reserves 3,637.48 3,124.77 2,754.38 2,536.64 2,374.69 1,959.59 1,650.56 1,352.37 1,174.35 916.28 Non-Current Liabilities 136.03 144.02 184.18 189.62 209.60 62.36 40.75 34.84 29.25 432.46 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 115.12 93.46 92.40 89.75 84.84 75.43 55.35 47.22 38.64 438.98 Current Liabilities 1,342.72 1,206.02 1,203.19 1,030.86 891.11 856.89 668.08 631.64 382.27 834.22 Trade Payables 1,002.69 891.99 889.45 762.67 657.77 663.52 480.62 474.69 230.14 193.56 Other Current Liabilities 191.79 177.30 174.02 136.76 118.25 89.42 81.80 77.90 86.90 59.35 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 148.24 136.73 139.72 131.43 115.09 103.96 105.66 79.05 65.23 581.31 Total Liabilities 5,177.64 4,538.58 4,207.16 3,822.64 3,532.41 2,927.84 2,401.59 2,053.42 1,607.12 2,204.21 Net Block 224.94 236.91 271.00 250.78 269.83 104.96 81.38 109.60 108.46 96.04 Gross Block 424.50 366.93 425.90 340.62 344.84 164.52 124.25 139.69 122.83 215.65 Accumulated Depreciation 199.56 130.02 154.90 89.84 75.01 59.56 42.87 30.10 14.37 119.61 Non Current Assets 1,931.80 1,513.47 354.12 335.23 327.76 166.85 136.12 160.41 156.49 540.81 Capital Work in Progress 10.11 3.66 0.66 0.66 1.64 0.73 2.17 6.28 2.83 3.91 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 80.18 97.88 79.35 78.80 50.91 56.69 48.91 41.53 42.47 438.62 Other Non Current Assets 1,616.57 1,175.02 3.11 4.99 5.38 4.47 3.66 3.00 2.73 2.24 Current Assets 3,245.84 3,025.11 3,853.04 3,487.41 3,204.65 2,760.98 2,265.47 1,893.02 1,450.63 1,663.39 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 619.58 648.85 687.82 717.59 527.17 606.79 585.33 500.63 370.10 384.13 Sundry Debtors 319.11 318.80 288.16 250.21 317.91 276.11 263.44 176.22 145.02 129.15 Cash & Bank 2,134.49 1,937.06 2,749.22 2,409.04 2,197.38 1,684.28 1,031.35 1,090.92 839.42 643.89 Other Current Assets 172.66 70.06 73.19 67.79 162.19 193.80 385.35 125.24 96.08 506.22 Short Term Loans & Adv. 85.54 50.34 54.65 42.78 105.79 93.24 289.55 106.23 79.51 488.68 Net Current Assets 1,903.12 1,819.09 2,649.85 2,456.55 2,313.54 1,904.09 1,597.39 1,261.38 1,068.36 829.17 Total Assets 5,177.64 4,538.58 4,207.16 3,822.64 3,532.41 2,927.83 2,401.59 2,053.43 1,607.12 2,204.20

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 1,212.81 893.39 947.66 726.74 626.13 499.13 152.70 307.22 248.68 214.78 PBT 1,617.75 1,273.82 1,079.73 925.95 802.70 698.85 621.48 436.49 398.01 344.36 Adjustment -129.85 -62.70 23.30 24.99 -17.22 -77.46 -76.92 -37.02 -23.98 -37.19 Changes in Working Capital 129.38 23.13 133.62 11.26 69.82 134.41 -186.96 66.52 21.85 23.48 Cash after chg. in Working capital 1,617.28 1,234.25 1,236.65 962.20 855.30 755.80 357.61 466.00 395.87 330.65 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -404.47 -340.86 -288.99 -235.46 -229.17 -256.67 -204.90 -158.78 -147.20 -115.87 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -416.03 -147.71 -395.84 -71.82 -401.21 -257.00 -214.84 -155.41 -77.19 -186.72 Net Fixed Assets -64.02 55.97 -85.28 5.20 -181.23 -38.83 19.55 -20.31 93.90 -9.06 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others -352.01 -203.68 -310.56 -77.02 -219.98 -218.17 -234.39 -135.10 -171.09 -177.66 Cash from Financing Activity -744.71 -638.72 -637.38 -581.79 -216.79 -142.80 -102.43 -89.76 -80.29 -57.58 Net Cash Inflow / Outflow 52.07 106.96 -85.56 73.13 8.13 99.33 -164.56 62.05 91.19 -29.52 Opening Cash & Equivalents 239.67 132.71 218.27 145.14 137.01 37.68 202.24 140.19 49.00 78.52 Closing Cash & Equivalent 291.74 239.67 132.71 218.27 145.14 137.01 37.68 202.24 140.19 49.00

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 1721.76 1480.48 1306.18 1203.71 1127.50 932.19 786.76 646.43 562.65 441.20 ROA 24.73% 21.71% 19.89% 18.78% 18.36% 16.90% 18.01% 15.12% 13.39% 11.20% ROE 35.31% 32.07% 29.95% 27.89% 27.09% 24.66% 26.35% 21.54% 23.93% 26.54% ROCE 47.34% 42.93% 40.53% 37.52% 36.54% 37.88% 40.61% 33.96% 37.55% 39.98% Fixed Asset Turnover 15.27 13.85 13.12 13.04 16.07 25.48 25.06 22.39 15.63 10.91 Receivable days 19.26 20.18 19.54 23.19 26.49 26.77 24.26 19.95 18.91 18.77 Inventory Days 38.30 44.44 51.02 50.82 50.56 59.14 59.93 54.07 52.03 58.54 Payable days 107.36 109.28 113.47 108.42 78.62 76.56 66.93 54.71 38.57 32.92 Cash Conversion Cycle -49.80 -44.66 -42.91 -34.41 -1.57 9.35 17.26 19.31 32.37 44.39 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 130.94 80.66 57.53 51.65 95.10 311.82 163.60 215.33 158.63 685.07

Top Investors:

sbi retirement benefit fund

canara robeco mutual fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Abbott, MSD Pharmaceuticals enter into partnership
19th Jun 2025, 14:12 PM

The companies have entered into partnership for distribution of oral anti-diabetic medicines in India
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback